Korea signs industryacademia partnership with India for drug discovery

South Korea-based drug discovery firm PharmCADD has recently signed a Memorandum of Understanding (MoU) with the Indian Institute of Technology, Hyderabad (IIT-H) for co-developing new drugs and advancing the platform technology, pharmulator. PharmCADD has founded a local corporation in India and is intensively hiring competent Indian researchers. Under this MoU, IIT-H will provide PharmCADD with key members to conduct academic research in the field of artificial intelligence (AI), molecular dynamics (MD) simulation, and quantum calculation for new drug development. PharmCADD and IIT-H have also agreed to promote collaboration by jointly participating in global R&D projects. India holds the world’s third-largest AI capability, publishing 80,000 papers in the field of AI over the past five years. IIT-H is the only institute in the country with undergraduate programmes in both Biomedical Engineering and Biotechnology & Bioinformatics.